Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis
Open Access
- 31 October 2006
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 45 (4), 584-591
- https://doi.org/10.1016/j.jhep.2006.05.011
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Treatment strategies in autoimmune hepatitisClinics in Liver Disease, 2002
- Current and novel immunosuppressive therapy for autoimmune hepatitisHepatology, 2002
- Autoimmune hepatitis: Clinical challengesGastroenterology, 2001
- Autoimmune hepatitis: The investigational and clinical challengesHepatology, 2000
- Azathioprine for Long-Term Maintenance of Remission in Autoimmune HepatitisThe New England Journal of Medicine, 1995
- Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitisHepatology, 1992
- Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphismClinical Pharmacology & Therapeutics, 1989
- Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawalHepatology, 1988
- Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.Gut, 1975
- Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic HepatitisQJM: An International Journal of Medicine, 1971